Opinions
Jim Cramer - Mad Money
FibroGen
FGEN-Q
COMMENT
Nov 02, 2020
A totally speculative play, so earnings don't matter. They report Wednesday. They're testing an anemia drug in phase 3 now.
$39.200
Stock price when the opinion was issued
biotechnology
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.